Healthcare Sales & Marketing Network News: Microspheres

Searching News Database: Microspheres

HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Devices Oncology Personnel

HSMN NewsFeed - 5 Dec 2023
ABK Biomedical Announces That its Eye90 Microspheres(R) Device Has Been Granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA)
Devices Oncology FDA

HSMN NewsFeed - 10 Aug 2022
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Devices Interventional

HSMN NewsFeed - 9 Feb 2022
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres(R) Y-90 resin microspheres in China from the National Medical Products Administration
Devices Oncology Regulatory

HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA

HSMN NewsFeed - 11 Oct 2021
Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres(R) Y-90 resin microspheres in China
Devices Oncology

HSMN NewsFeed - 22 Mar 2021
Sirtex Medical announces new SIR-Spheres(R) DOORwaY-90 Study: The first prospective multicenter U.S.-based trial for registration as first-line treatment for hepatocellular carcinoma
Devices Oncology

HSMN NewsFeed - 18 Mar 2021
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
Devices Oncology FDA

HSMN NewsFeed - 9 Dec 2020
Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Devices Oncology Venture Capital

HSMN NewsFeed - 7 Oct 2020
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business
Devices Dermatology Acquisitions

HSMN NewsFeed - 15 Jul 2020
Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field
Devices Interventional Oncology Mergers & Acquisitions

HSMN NewsFeed - 3 Jun 2020
Sirtex Medical appoints Dr. Mark A. Turco as Global Chief Medical Officer and EVP of Research & Development
Devices Oncology Personnel

HSMN NewsFeed - 2 Apr 2020
Boston Scientific Provides Update on COVID-19 Impact and Response Efforts
Devices

HSMN NewsFeed - 19 Aug 2019
Boston Scientific Closes Acquisition of BTG plc.
Devices Interventional Oncology Mergers & Acquisitions

HSMN NewsFeed - 23 Jul 2019
Recommendations for Personalised HCC Treatment With Y90 TheraSphere(TM) Published by an International Multidisciplinary Group
Devices Interventional Oncology

HSMN NewsFeed - 21 Dec 2018
BTG Announces National Reimbursement for TheraSphere(R) in France
Devices Oncology Reimbursement

HSMN NewsFeed - 20 Nov 2018
Boston Scientific Announces Recommended Offer to Acquire BTG plc.
Devices Interventional Oncology Mergers & Acquisitions

HSMN NewsFeed - 27 Sep 2018
FDA Grants Profounda Inc. Competitive Generic Therapy (CGT) Designation for planned ANDA filing of Minocycline Hydrochloride Microspheres,1 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Jul 2018
ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer
Devices Oncology Personnel

HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Biopharmaceuticals Neurology Acquisitions

HSMN NewsFeed - 30 Jan 2018
Varian Signs Agreement to Acquire Sirtex
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 3 Jul 2017
New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
Devices Oncology

HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology

HSMN NewsFeed - 19 Oct 2016
First Patient in Malaysia Receives TheraSphere(TM) Radioembolization Therapy
Devices Oncology

HSMN NewsFeed - 14 Oct 2016
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y(TM) Dosimetry Software in Europe
Devices Oncology Regulatory

HSMN NewsFeed - 11 Oct 2016
New European Society of Medical Oncology (ESMO) Biliary Cancer Guidelines Indicate Selective Internal Radiation Therapy (SIRT) with Y-90 Microspheres as an Option for Post-Chemotherapy Treatment of Intrahepatic Cholangiocarcinoma (iCCA)
Devices Oncology

HSMN NewsFeed - 25 Aug 2016
Sirtex Medical Inc. Announces 19 Percent Dose Sales Growth of SIR-Spheres(R) Y-90 resin microspheres in Fiscal Year 2016
Devices Oncology

HSMN NewsFeed - 1 Jul 2016
Patients with Colorectal Cancer Liver Metastases Had Significantly Greater Depth of Tumour Response to SIR-Spheres(R) Y-90 resin microspheres, New SIRFLOX Analysis Shows
Devices Oncology

HSMN NewsFeed - 26 May 2016
New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma
Devices Oncology

HSMN NewsFeed - 4 Apr 2016
First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON(R) (sulfur hexafluoride lipid-type A microspheres) for Injectable Suspension, for Intravenous Use
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 31 Mar 2016
SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says
Devices Oncology

HSMN NewsFeed - 23 Feb 2016
SIRFLOX Study Published in Journal of Clinical Oncology
Devices Interventional Radiology Oncology

HSMN NewsFeed - 14 Dec 2015
BTG Announces FDA Clearance for LC Bead LUMI(TM), the First Commercially Available Radiopaque Embolic Bead in the US
Devices Interventional FDA

HSMN NewsFeed - 2 Dec 2015
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
Devices Interventional Radiology Oncology Venture Capital

HSMN NewsFeed - 10 Nov 2015
Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
Devices Interventional Radiology Oncology Acquisitions

HSMN NewsFeed - 25 Sep 2015
Surefire Medical Launches Advanced Precision Direct-To-Tumor Infusion System At CIRSE
Devices Interventional Oncology Product Launch

HSMN NewsFeed - 13 Aug 2015
Sirtex Medical Inc. Announces 21.2 Percent Dose Sales Growth of SIR-Spheres(R) Y-90 resin microspheres in Fourth Quarter
Devices Oncology Interventional

HSMN NewsFeed - 17 Mar 2015
Sirtex Reports Preliminary SIRFLOX Study Results
Devices Drug Delivery Oncology

HSMN NewsFeed - 6 Nov 2013
Acusphere Appoints Dr. William Ramage as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jul 2013
Merit Medical Announces Multiple Regulatory Approvals
Devices Interventional FDA Regulatory

HSMN NewsFeed - 30 May 2013
SIR-Spheres(R) microspheres as Effective and Safe in the Elderly as they are in Younger Patients with Colorectal Liver Metastases According to Data Released at ASCO Annual Meeting
Devices Drug Delivery Oncology

HSMN NewsFeed - 9 May 2013
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 7 Mar 2013
Merit Medical Receives CE Mark for Prostatic Artery Embolization for Embosphere(R) Microspheres
Devices Urology Regulatory

HSMN NewsFeed - 11 Dec 2012
Sirtex Medical Limited Launches New Global Website for SIR-Spheres(R) Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours
Devices Oncology

HSMN NewsFeed - 15 Aug 2012
Sirtex Medical Inc. Expands U.S. Operations to Accommodate Increased Demand for SIR-Spheres Microspheres
Devices Oncology

HSMN NewsFeed - 23 Mar 2012
Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves Survival for Cancer Patients with Inoperable Liver Tumours
Devices Oncology

HSMN NewsFeed - 6 Sep 2011
Oceana Therapeutics Announces U.S. Launch of Solesta(R), The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence
Devices

HSMN NewsFeed - 3 Jun 2011
Fox Chase Cancer Center Study Evaluating the Safety of Concurrent Chemotherapy and Selective Internal Radiation Therapy using SIR-Spheres(R) Microspheres Released at 2011 American Society of Clinical Oncology Annual Meeting
Devices Oncology

HSMN NewsFeed - 31 May 2011
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence
Devices Gastroenterology FDA

HSMN NewsFeed - 7 Apr 2011
Oceana Therapeutics Gets FDA Approvable Letter for Solesta(R), a Significant Treatment Option for Fecal (Bowel) Incontinence; the Only Minimally Invasive Therapy for More Severe Bowel Control Problems
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2010
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
Devices Ophthalmology Drug Delivery

HSMN NewsFeed - 14 Jul 2010
CardioGenics And Merck In Second Product Agreement
Diagnostics Cardiology

HSMN NewsFeed - 10 Mar 2010
CardioGenics Announces Further Update Regarding Status of Merck Agreement
Diagnostics

HSMN NewsFeed - 19 Jan 2010
Sirtex Appoints Michael Mangano to Lead U.S. Operations
Devices Oncology Personnel

HSMN NewsFeed - 7 Oct 2009
Study Shows Uterine Artery Embolization Compares Favorably to Laparoscopic Bilateral Occlusion for Treating Uterine Fibroids
Devices Interventional

HSMN NewsFeed - 6 Oct 2009
Scientific Paper Supports Micro-Bland Embolization Technique for Liver Cancer With Embozene(TM) Microspheres
Devices Oncology

HSMN NewsFeed - 16 Sep 2009
New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
Devices Oncology

HSMN NewsFeed - 17 Aug 2009
BioSphere Medical Announces New Journal Articles Published Discussing Uterine Fibroid Embolization
Devices

HSMN NewsFeed - 1 Jun 2009
Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients with Colorectal Cancer Liver Metastases who have Exhausted Chemotherapy
Biopharmaceuticals Oncology Gastroenterology

HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 27 Apr 2009
RISPERDAL CONSTA Approved in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Apr 2009
BioSphere Medical Enters into Exclusive Distribution Agreement with Nippon Kayaku for Japanese Market
Devices Distribution

HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Jan 2009
First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional Oncology

HSMN NewsFeed - 16 Dec 2008
CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
Devices Interventional FDA

HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology

HSMN NewsFeed - 25 Sep 2008
Acusphere, Inc. Appoints Michael Slater SVP Regulatory Affairs and Operations Replacing Dennis Bucceri
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2008
BioSphere Medical Announces ACOG Practice Bulletin Recommendation of Uterine Artery Embolization as Alternative to Hysterectomy
Devices

HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 21 May 2008
Sirtex Launches Global Clinical Trial Comparing the Use of SIR-Spheres(R) Microspheres Plus Chemotherapy versus Chemotherapy Alone as First Line Treatment for Metastatic Colorectal Cancer
Devices Oncology

HSMN NewsFeed - 14 May 2008
Sirtex Sponsors Pilot Study Evaluating SIR-Spheres(R) Microspheres for the Treatment of Unresectable Hepatocelluar Carcinoma
Devices Interventional Oncology

HSMN NewsFeed - 9 May 2008
Artes Medical Reports Strong Consumer Interest, Rapid Patient Enrollment and Positive Feedback in Largest U.S. Dermal Filler Clinical Study
Devices Dermatology

HSMN NewsFeed - 19 Apr 2008
Artes Medical Announces Operating Cost Reductions in Conjunction with Newly Expanded Sales Force and Marketing Activities for Commercialization of ArteFill
Devices Dermatology

HSMN NewsFeed - 14 Apr 2008
Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch
Biopharmaceuticals Dermatology

HSMN NewsFeed - 31 Mar 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 28 Mar 2008
BioSphere Medical Commences Sales of Embosphere(R) Microspheres in the People's Republic of China
Devices Interventional

HSMN NewsFeed - 24 Mar 2008
Sirtex Announces New President for U.S. Operations
Devices Personnel

HSMN NewsFeed - 20 Feb 2008
Luminex Corporation Places 5,000th Instrument
Diagnostics

HSMN NewsFeed - 14 Feb 2008
BioSphere Medical Names Willard W. Hennemann, Ph.D. Vice President, New Product and Business Development
Devices Personnel

HSMN NewsFeed - 28 Jan 2008
BioSphere Medical Receives Market Clearance to Sell Embosphere(R) Microspheres in the People's Republic of China
Devices Regulatory

HSMN NewsFeed - 22 Jan 2008
BioSphere Medical Names Joel B. Weinstein Vice President of Global Marketing and Sales
Devices Personnel

HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Devices Interventional

HSMN NewsFeed - 20 Jan 2008
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Devices Interventional Cardiology

HSMN NewsFeed - 15 Jan 2008
Study Published in the Journal of Vascular and Interventional Radiology Concludes That Embosphere(R) Microspheres Should Be the Preferred Agent for Uterine Fibroid Embolization When Compared to Boston Scientific's Contour SE(TM) PVA Microspheres
Devices Interventional

HSMN NewsFeed - 8 Jan 2008
Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 4 Jan 2008
New Chairman for Oncologix Tech, Inc. Issues Statement
Devices Oncology Personnel

HSMN NewsFeed - 11 Dec 2007
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
Biopharmaceuticals Dermatology Personnel

HSMN NewsFeed - 10 Dec 2007
Dermatologic Surgery Journal Publishes Landmark Study Showing Positive Five-Year Effects of ArteFill for Smile Lines
Biopharmaceuticals Dermatology

HSMN NewsFeed - 27 Nov 2007
ArteFill in Head to Head Investigator-Initiated Study to Test Comparative Duration, Safety, and Patient Preference for Dermal Fillers for the Treatment of Smile Lines
Biopharmaceuticals Dermatology

HSMN NewsFeed - 6 Nov 2007
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress Echo is Well-tolerated and as Effective as Nuclear Perfusion Imaging for Evaluating Chest Pain Patients at Risk for Heart Attack
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Nov 2007
Acusphere to Develop Potential Abraxane(R) Bioequivalent
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 31 Oct 2007
Artes Medical's 5-Year Safety and Efficacy Data Presented at the American Society of Plastic Surgeons (ASPS) Conference
Devices Dermatology

HSMN NewsFeed - 3 Oct 2007
Acusphere Appoints New Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Oct 2007
Acusphere Provides Update on Progress toward NDA Filing for Imagify(TM)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Oct 2007
Robert B. Sherman, Former AOL and Time Warner Division President, Joins Artes Medical's Board of Directors
Devices Personnel

HSMN NewsFeed - 1 Oct 2007
Beverly A. Huss, CEO OF Vibrynt and Former Division President of Guidant Joins Artes Medical's Board of Directors
Devices Personnel

HSMN NewsFeed - 15 Aug 2007
Merit Medical Announces Exclusive Distribution Deal for Microcatheter
Devices Distribution Interventional

HSMN NewsFeed - 9 Aug 2007
Review Examines the Use of Sirtex's SIR-Spheres(R) Microspheres in Patients with Hepatic Colorectal Cancer Metastases
Devices Oncology

HSMN NewsFeed - 17 Jul 2007
Artes Medical Names Greg J. Kricorian, M.D. as Its Chief Medical Officer
Devices Dermatology Personnel

HSMN NewsFeed - 12 Jul 2007
Sirtex Announces New Medical Director for U.S. Operations
Devices Oncology Personnel

HSMN NewsFeed - 21 Jun 2007
BioSphere Medical Announces Departure of Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 12 Jun 2007
Artes Medical Forms New Subsidiary to Commercially Develop and License Medical Applications of Its Microsphere Technology
Devices Dermatology

HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 1 May 2007
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
Biopharmaceuticals Radiology

HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 17 Apr 2007
ArteFill 5-Year Data to Be Presented at American Society for Aesthetic Plastic Surgery Annual Meeting
Biopharmaceuticals Dermatology

HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Apr 2007
Tepha, Inc. Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
Devices Surgery FDA

HSMN NewsFeed - 21 Mar 2007
Artes Medical Submits Five Year Artefill(R) Clinical Results to FDA
Devices Dermatology

HSMN NewsFeed - 6 Mar 2007
Acusphere Announces Key Promotions in Research and Development
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 13 Feb 2007
Sirtex Supports the First Pilot Study Evaluating SIR-Spheres(R) Microspheres in Combination with Bevacizumab and Chemotherapy as a First Line Treatment for Metastatic Colorectal Cancer
Devices Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Feb 2007
Artes Medical Promotes Peter C. Wulff -- Executive Vice President
Devices Personnel

HSMN NewsFeed - 7 Feb 2007
Artes Medical Announces Commercial Launch of ArteFill(R)
Devices

HSMN NewsFeed - 1 Feb 2007
Artes Medical Announces Landmark Five Year Study Results for ArteFill, a Non-Resorbable Dermal Filler
Biopharmaceuticals Dermatology

HSMN NewsFeed - 17 Jan 2007
MedicalCV Elects Two Senior Medical Device Executives to Its Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 12 Jan 2007
AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition
Devices Mergers & Acquisitions

HSMN NewsFeed - 27 Dec 2006
FDA Approves Radiesse(R) Facial Filler for Two New Aesthetic Indications
Devices Dermatology FDA

HSMN NewsFeed - 30 Nov 2006
RITA Medical Systems Announces Market Release of Habib 4X Laparoscopic(TM)
Devices Surgery

HSMN NewsFeed - 28 Nov 2006
AngioDynamics to Acquire RITA Medical for $220 Million
Devices Mergers & Acquisitions

HSMN NewsFeed - 9 Nov 2006
BioSphere Medical Receives FDA Approval For QuadraSphere(TM) Microspheres
Devices Interventional FDA

HSMN NewsFeed - 30 Oct 2006
Artes Medical Announces FDA Approval for ArteFill(R) as the First Non-Resorbable Injectable Wrinkle Filler to Correct Smile Lines
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 26 Oct 2006
RITA Medical Initiates Feasibility Study of Device for RFA-Assisted Breast Lumpectomy
Devices Oncology

HSMN NewsFeed - 17 Oct 2006
RITA Medical Systems Announces FDA 510(k) Clearance of HABIB 4X Laparoscopic(TM) Device
Devices Surgery FDA

HSMN NewsFeed - 3 Oct 2006
RITA Medical Highlights Recent Clinical Publications Discussing Local Therapy Devices in the Treatment of Liver Tumors Associated With Colorectal Cancer
Devices Oncology

HSMN NewsFeed - 20 Sep 2006
Acusphere Hires Jonathan Jaffe, M.D. in Newly Created Position of Vice President Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 Jul 2006
Ocera Therapeutics, Inc. Raises $12 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jul 2006
Sirtex Medical Inc. Names U.S. CEO of Sales and Marketing Operations
Devices Oncology Personnel

HSMN NewsFeed - 9 May 2006
Sirtex Presents SIR-Spheres(R) Microspheres Data at the American Brachytherapy Society 2006 Meeting
Devices Oncology

HSMN NewsFeed - 8 May 2006
Sirtex Announces Clinical Trial Evaluating the Use of SIR-Spheres(R) Microspheres with Xeloda(R) for Metastatic Liver Cancer
Devices Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 80

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 80 additional stories matching:
Microspheres
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.